| |
|
|
|
|
|
|
|||
|
IMMUNOBIOLOGY
From the Department of Immunology, Erasmus
University Rotterdam/University Hospital Rotterdam, The
Netherlands.
T-cell receptor (TCR) gene rearrangements are mediated via V(D)J
recombination, which is strictly regulated during lymphoid differentiation, most probably through the action of specific transcription factors. Investigated was whether cotransfection of
RAG1 and RAG2 genes in combination with
lymphoid transcription factors can induce TCR gene
rearrangements in nonlymphoid human cells. Transfection
experiments showed that basic helix-loop-helix transcription
factors E2A and HEB induce rearrangements in the TCRD locus
(D Antigen recognition by lymphocytes is dependent
upon successful rearrangement of immunoglobulin and T-cell
receptor (TCR) genes from variable (V), diversity (D), and joining (J)
gene segments through the process of V(D)J recombination.1
The rearrangement processes are mediated by the
recombination-activating gene (RAG)-1 and RAG2 proteins, which
specifically recognize the recombination signal sequences (RSSs) that
flank the coding regions of the V, D, and J gene
segments.2-4 RSSs are consensus sequences consisting of a
heptamer and nonamer separated by a 12-base pair (bp) or 23-bp spacer.
Site-specific cleavage at the borders of RSSs and coding elements by
the RAG proteins is followed by a process of rejoining of DNA ends in
which the double-strand break-repair enzymes play a central role.
Antigen receptor assembly is critically dependent upon expression of
the lymphoid-specific RAG proteins; this is further illustrated by the
fact that ectopic RAG expression results in site-specific recombination
both in vitro and in vivo.2-4
The whole process of V(D)J recombination is ordered and tightly
regulated during lymphoid differentiation.5 The
hierarchical order is apparent at different levels. First, cells
committed to the B-cell lineage undergo immunoglobulin rearrangements,
whereas TCR genes rearrange in T-cell precursors. Nevertheless,
so-called cross-lineage rearrangements might occasionally occur in
precursor B and T cells; this phenomenon is particularly evident from
malignantly transformed lymphoid precursor cells, ie, B- and T-lineage
acute lymphoblastic leukemias (ALLs).6,7 Furthermore,
immunoglobulin (Ig) heavy chain (IGH) rearrangements are
known to precede Ig kappa (IGK) and Ig lambda
light-chain recombination.8 Similarly, data from human
T-ALL and sorted human thymocyte subpopulations indicate that TCR It has been suggested that the tight and hierarchical regulation of the
rearrangement processes can be explained by differential chromatin
accessibility to the V(D)J recombinase,16 which in turn is
controlled by transcription factors binding to promoters and enhancers.
E proteins are an important class of transcription factors in lymphoid
differentiation. They consist of a helix-loop-helix (HLH) dimerization
motif and a basic DNA binding domain that binds to conserved E-box
motifs, as identified in immunoglobulin, TCRB, and CD4
enhancers. Members of the E-protein family include E2-2, HEB, and the
E12 and E47 splice variant products of the E2A
gene.17 E12 and E47 are differentially expressed in a wide
variety of tissues, but exist as homodimers only in B-lineage
cells.18,19 In T cells, E-box binding complexes are
heterodimers of E2A and HEB. E2A It is now generally accepted that V(D)J recombination processes are
also involved in the formation of particular chromosome aberrations in
human leukemias.25-27 This especially concerns aberrations in human T-ALL, in which TCRB or TCRD gene
segments are translocated to oncogenes, resulting in activation of
these oncogenes through TCR regulatory elements.28
Although little is known about the exact molecular processes, it is
tempting to speculate that transcription factor-induced accessibility
of the involved loci is a critical step in the formation of these aberrations.
Here we show that 2 types of E proteins, E2A and HEB, have the
ability to target the recombination machinery to TCR loci in nonlymphoid cells. Expression of E2A or HEB in the presence of RAG1/RAG2 appeared to induce immature types of TCRD
rearrangements, several TCRG rearrangements, but no
TCRB recombination.
Cell culture
DNA constructs
Transfection protocol Transfections were performed via calcium phosphate precipitation as described.23 BOSC 23 cells were plated on the day prior to transfection at a density of 4.5 × 106 cells per 10-cm dish. On the day of the transfection, 18 to 24 µg total DNA, including 6 µg each expression vector or carrier DNA, was used per transfection. The cells were harvested 3 days after transfection.Polymerase chain reaction analysis of TCR rearrangements (coding and signal joints) By polymerase chain reaction (PCR), 200 ng genomic DNA, isolated from the various BOSC 23-transfected cell cultures, was analyzed in a 50-µL reaction volume containing 1 × Taq Gold buffer (Applied Biosystems, Foster City, CA), 1.5 mM MgCl2, 12.5 pmol each primer, 200 µM deoxy-nucleoside 5' triphosphate, and 1 U AmpliTaq Gold (Applied Biosystems). PCR reactions were performed on an ABI480 machine as follows: 10 minutes preactivation at 94°C, 40 cycles of 45 seconds at 94°C, 90 seconds at 60°C, 2 minutes at 72°C, followed by a 10-minute extension at 72°C. The primers used to detect TCRD rearrangements as well as their circular excision products locus are listed in Table 1. TCRG gene rearrangements were studied with the use of V I-3', V II-3', V III-3',
V IV-3', J 1.1/2.1-3', J 1.2-3', and J 1.3/2.3-3'
primers.33 TCRB analysis was performed with
V 2 and V 5A family primers (A.W.L., unpublished data,
2001) or D 1 and D 2 primers (T. Szczepanski, unpublished results, 2001) in combination with J 1(2) and
J 2(2) primers.34 Deletional rearrangements in
the TCRD locus were studied with the use of REC-3' and
J -3' primers (Table 1).35 In all reactions, proper
positive controls for the various types of TCR rearrangements were
included: well-defined leukemic cell DNA and/or total thymus DNA. We
used mock-transfected BOSC 23 cells and/or HeLa genomic DNA as template
containing negative controls. We analyzed 20 µL each PCR on a 2%
agarose gel, followed by ethidium bromide staining. If TCR
rearrangements were detected in the agarose gels, the remainder of the
PCR products were subjected to heteroduplex analysis to discriminate
between monoclonal and polyclonal rearrangements.36 In
short, heteroduplex analysis consisted of 5 minutes
denaturation at 94°C and 60 minutes renaturation at 4°C
prior to electrophoresis on 6% nondenaturing polyacrylamide gels
(polyacrylamide to bisacrylamide, 29:1) in 0.5 × TBE
buffer.36 Ethidium bromide-stained homoduplex or
heteroduplex PCR products were visualized with UV light.
Cloning of PCR products and sequencing Following amplification, PCR products were purified by means of QIAquick PCR purification kits (Qiagen, Hilden, Germany) and cloned into pGEM-T Easy vector (Promega, Madison, WI) according to the manufacturer's instructions. Clones containing insert were sequenced on the ABI377 fluorescent sequencer, by means of the dye terminator cycle sequencing kit and AmpliTaq FS (Applied Biosystems).7Real-time quantitative PCR of TCR rearrangements Levels of particular rearranged TCRD and TCRG PCR products were quantified by real-time quantitative (RQ) PCR, by means of TaqMan technology on the ABI Prism 7700 Sequence Detection System (Applied Biosystems), as described earlier.37-39 To this end, forward (F-DD2-KLON, F-VG8-KLON) and reverse primers (R-DD3-CONS4, R-JG13/23-KLON) (Table 1) were designed by means of Primer Express (Applied Biosystems) and Oligo6.2 (Dr W. Rychlik, Molecular Biology Insights, Cascade, CO) software to select melting temperature values of 58°C to 60°C and to exclude hairpin formation, dimer formation, and false priming. Design of the primers was performed so that the primers could be used with already present dual-labeled TaqMan probes (T-DD3-CONS2, T-JG13/23-CONS3) (Table 1). An albumin primer/probe RQ-PCR set (Applied Biosystems) was used to quantitate and normalize the amount of DNA used in the various transfections.37
E2A and HEB induce incomplete TCRD gene rearrangements in nonlymphoid cells To study the effect of E-box proteins on recombination events in the various human TCR loci, we employed the model system described by Romanow et al.23 Nonlymphoid BOSC 23 cells, which harbor their TCR loci in germline configuration, were transfected with E2A, splice variants (E12 or E47), or HEB, either alone or in combination with the RAG1/RAG2 proteins. PCR analysis of genomic DNA, isolated 3 days posttransfection, was performed by means of specific primers for the most frequently occurring types of incomplete and complete TCRD gene rearrangements (D 2-D 3, V 2-D 3, D 2-J 1, V 1-J 1, V 2-J 1, V 3-J 1 recombinations)
(Figure 1A). Transfection of E2A or HEB
alone, or mock transfection, did not result in activation of any of
these rearrangements. However, D 2-D 3 and V 2-D 3
rearrangements were clearly induced upon transfection of either E2A or
HEB in combination with the 2 RAG genes (Figure 1B-C).
In contrast to V 2-D 3 rearrangements, D 2-D 3 recombination products were also detectable in transfectants with the 2 RAG genes
only. However, quantification by RQ-PCR with the TaqMan technology
revealed that the D 2-D 3 rearrangement levels were essentially
higher (5- to 10-fold) in the HEB-plus-RAG transfectants than in the
RAG1/RAG2-only transfectants. Further cloning and sequencing of the
PCR products from the various transfectants showed heterogeneous
V 2-D 3 junctional regions in all transfection combinations, with
variable numbers of deleted nucleotides at both sides and
occasionally introduction of palindromic (P) nucleotides (Table
2). Strikingly, virtually all sequenced
D 2-D 3 rearrangements of the transfected cells were found to be
identical, showing complete deletion of the D 2 and D 3 gene
segments and direct coupling of the upstream RSS of the D 2 segment
to the downstream RSS of the D 3 segment (Table 2, Figure
2). This so-called signal joint, which is
normally present in excision circles, was only occasionally found in
normal thymocytes (Table 2, Figure 2).
In contrast to the D
TCRD recombination involving J -J rearrangements
are formed via multiple (consecutive) couplings involving D
segments, rather than as a direct joining of V to J gene
segments. This even applies to D 2-J 1 joints that are known to be
formed in 2 steps, given the presence of identifiable D 3 segment
sequences in virtually all of these coding joints.40,41 To
determine whether E2A or HEB can induce recombination to J 1, we
studied a rarer type of TCRD rearrangement, D 3-J 1,
which can occur only as a direct coupling and which is known to be
present in human thymocytes (T. M. Breit et al, unpublished
observations, 2001). Although readily detectable in
thymocytes, this rearranged D 3-J 1 product could not be detected
in any of the transfected cell populations; the only PCR product
apparent was the larger germline fragment encompassing the
nonrearranged D 3 and J 1 segments that lie within 1 kb (Table 3).
Even after nested PCR, no clear signs of D 3-J 1 rearrangements
were found (data not shown), and also no D 3-J 1 signal joints were
detectable (Table 3). To fully exclude recombination to J gene
segments, we studied another type of TCRD rearrangement, D 3-J 3, which is also formed in a 1-step reaction and occurs in
thymocytes as well. Also this type of coupling (either coding joint or
signal joint) could not be observed in any of the transfected combinations (Table 3). Collectively, these data illustrate that E2A
and HEB have the ability to induce recombination in the TCRD locus, but that this concerns only 1-step rearrangements in the V 2-D region, and not in the more downstream J region.
V-J rearrangements in the TCRG locus are induced by E2A and HEB in cooperation with the RAG proteins Although the TCRD locus is generally believed to be the first TCR locus that is rearranged during T-cell differentiation, we wished to ascertain whether in the transfected BOSC 23 cells recombination events would also be detectable in the TCRG locus, which starts rearranging later than TCRD during thymocyte differentiation, but earlier than the TCRB and TCRA genes.9-11 The human TCRG locus is composed of a limited set of V gene
segments that are grouped in V families and 5 J gene segments
clustered in the homologous J 1 and J 2 regions (Figure
4A). To analyze V -J recombinations, we employed 4 V family primers in combination with 3 primers known
to recognize the J 1.1/2.1, J 1.2, and J 1.3/2.3 segments. V I-J 1.3/2.3 products were found to be induced by the basic HLH (bHLH) proteins E2A or HEB in the presence of RAG proteins as compared
with RAG proteins only (Figure 4B). Similar to D 2-D 3 recombination levels, TaqMan RQ-PCR revealed an inducing effect (3- to
5-fold) in the E2A or HEB plus RAG transfectants as compared with transfections with the RAG genes alone. Heteroduplex analysis of
the V -J PCR products to discriminate between polyclonal and clonal recombination products revealed some level of heterogeneity in
the various transfection combinations (data not shown). Since the V I
gene family consists of many distinct V gene segments that can
rearrange, we sequenced these V I-J 1.3/2.3 recombinations to study
the diversity of V gene segment usage (Table
4). All (approximately 20) sequenced
products were found to contain the J 2.3 gene segment, which is
discernible from J 1.3 at a single nucleotide position. At the V
side, 2 gene segments were identified: V 7 and V 8.
Interestingly, within the V I cluster, these 2 segments are most
proximal to the J segments (Figure 4A), which might explain their
predominance. Rearrangements between V IV (V 11) and J 1.3/2.3
gene segments were also observed in the E2A or HEB plus RAG
transfectants, but they could be found at similar levels in the
RAG1/RAG2 alone transfectants (data not shown). Apparently, the V IV
and J 2.3 gene segments are relatively easily accessible to the
action of the RAG proteins, even without the presence of lymphoid
transcription factors. The position of the V IV gene segment just
proximal to the J gene segments might explain the finding of the
otherwise rare V IV-J 1.3/2.3 recombination. Nevertheless, rearrangements between the V IV segment and the more proximal J
segments (J 1.1 and J 2.1) were not seen. Moreover, recombination products between any of the other V gene segments and these J 1.1 and J 2.1 segments were not detectable at all in the BOSC 23 transfectants. The same was true for V 9-J 1.2 rearrangements,
which are frequently found in peripheral blood TCR![]() + T
cells. The E2A and HEB bHLH proteins thus not only induce
TCRD recombination, but also direct the RAG proteins to
rearrange particular V and J gene segments within the
TCRG locus.
Absence of TCRB rearrangements and TCRD deletions in E2A and HEB transfectants To further analyze potential effects of E2A and/or HEB on V(D)J recombination in the TCR loci that are normally rearranged in later stages of T-cell differentiation (late double-negative and immature single-positive stages), we first studied rearrangements in the human TCRB locus. Unlike the TCRG locus, the TCRB locus is built up of a large number of distinct V
segments, clustered in approximately 25 V families, and 2 D
segments each lying upstream of a cluster of 6 or 7 J gene segments.
The presence of V, D, and J segments in the TCRB locus
implies that both incomplete and complete rearrangements can occur.
Incomplete TCRB rearrangements almost exclusively concern
D -J recombinations, as incomplete V -D joints are rarely
found in T cells. For this reason, we studied D 1-J 1, D 1-J 2,
and D 2-J 2 rearrangements, which can readily be detected in
thymocytes. However, we could not find either one of these products in
any of the transfected cell populations, even after nested PCR
reactions (data not shown). Given these results and also the results
from the TCRD analysis concerning 2-step recombinations, we
anticipated that V -J joints, which normally include D
sequences, would not be detectable either. Employing J 1 or J 2
primers in combination with specific primers for the frequently used
V 2 and V 5 families,42 we indeed could not observe
complete V -J joints (data not shown).
To further substantiate the absence of other mature TCR gene
rearrangements, we studied TCRD deletional rearrangements
mediated by the nonfunctional
In this study, we provide evidence that the bHLH transcription
factors E2A and HEB play a role in the induction of V(D)J recombination in human TCRD and TCRG loci, employing a
transfection-based model of nonlymphoid cells. E2A and HEB were found
to induce immature D The virtually identical patterns of TCR gene recombinations in both the
E2A plus RAG- and the HEB plus RAG-transfected cells showed a
striking similarity to the most immature types of rearrangements seen
in human thymocyte subpopulations (Table
5). D
In the transfected cells, V Although recombination can be induced relatively easily in this
transfection system, the efficiency seems to be too low to allow
detection of recombination events that occur in 2 consecutive steps.
This is best illustrated by our study on circular intermediate products
that are formed during recombination. Upon study of V From the initial V(D)J recombination study in this nonlymphoid model
system, it is known that induction of recombination by, eg, E2A is
critically dependent on activation domains.23 This has led
to the hypothesis that E-box proteins such as E2A are involved in
regulating chromatin accessibility by relieving the repressive effect
of nucleosomes, most probably through recruitment of complexes
containing histone acetyl transferase activity.23,50 We
therefore hypothesize that the interaction of E2A and HEB with chromatin leads to accessibility of RSS sequences of TCR loci as well,
which is supported by the observation of V The observations in this study raise the issue of how E2A and HEB are involved in regulating TCR recombination during in vivo T-cell differentiation. Both E2A and HEB knock-out mice show a block, though not complete, in the early double-negative stages of T-cell differentiation. The phenotype of these mice thus illustrates the important role of both E2A and HEB in the earliest phases of T-cell differentiation, although the incompleteness of the differentiation arrest indicates some degree of redundancy by other regulatory factors. Using the in vitro model, we show that some types of immature TCR rearrangements can be induced by E2A or HEB, whereas the absence of these rearrangements in E2A knock-out mice shows that E2A and HEB are probably also involved in stimulating the immature TCR recombination in vivo. For induction of further (more mature) rearrangements, additional cofactors or transcription factors might be required or negative regulatory elements might have to be downregulated at certain differentiation stages. Moreover, we cannot fully exclude a cooperative action of both E2A and HEB in particular recombinations in vivo, although we have not seen a synergistic effect of combined transfection of E2A and HEB with RAG proteins (data not shown). Besides mediating physiological immunoglobulin/TCR gene rearrangements, V(D)J recombination is also thought to be involved in the formation of particular chromosome aberrations in human leukemias.25,26 This especially concerns chromosome aberrations in T-ALL, in which TCRB or TCRD gene segments and their regulatory elements are translocated to oncogenes on partner chromosomes, resulting in activation of the oncogenes. Examples include translocations t(1;14) and t(11;14), involving the genes encoding the TAL1 and LMO1/LMO2 transcription factors, respectively.25,51 As the breakpoint regions on these chromosomes have been found to be located near RSS or RSS-like sequences,25-27 it is suggestive that accessibility of the involved oncogenes to RAG protein activity might be a critical step in the formation of these chromosome aberrations as well. We therefore also studied TAL1 deletions, which are V(D)J-like rearrangements that are found exclusively in T-ALL, particularly in T-ALL with TCRD deletions.52 However, such RSS-mediated TAL1 deletions were not induced upon E2A or HEB transfection (data not shown). Given the relatively low frequency of V(D)J recombinations in nonlymphoid cells, it can be argued that detection of TAL1 deletions in this model system would be very difficult. However, it might also be that transcription factors other than E2A and HEB regulate accessibility of the TAL1 gene and that an aberrant combination of regulatory factors is required to induce these unwanted oncogenic TAL1 deletions. In summary, our data demonstrate a role for the bHLH proteins E2A and
HEB in induction of TCR rearrangements. Comparison with the
TCR-rearrangement patterns found in thymocyte subsets and in T- and
B-lineage leukemias indicates that the identified rearrangements in,
especially, the TCRD locus are immature and carry a less
T-cell-specific character (Figure 5). A challenge for future studies
remains the identification of factors that are involved in induction of
more T-cell-specific TCR rearrangements, such as (complete)
TCRD recombinations involving J
Dr R. Benner for continuous support and Drs F. J. T. Staal and T. Szczepanski for critical reading and valuable comments.
Submitted March 7, 2001; accepted May 10, 2001.
Supported by grant EUR 95-1015 from the Dutch Cancer Society (Koningin Wilhelmina Fonds); and additional financial support (to A.W.L.) from the Haak Bastiaanse Kuneman Foundation.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Anton W. Langerak, Department of Immunology, Erasmus University Rotterdam/University Hospital Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands; e-mail: langerak{at}immu.fgg.eur.nl.
1. Tonegawa S. Somatic generation of antibody diversity. Nature. 1983;302:575-581[CrossRef][Medline] [Order article via Infotrieve]. 2. Schatz DG, Oettinger MA, Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell. 1989;59:1035-1048[CrossRef][Medline] [Order article via Infotrieve].
3.
Oettinger MA, Schatz DG, Gorka C, Baltimore D.
RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
Science.
1990;248:1517-1523 4. van Gent DC, McBlane JF, Ramsden DA, Sadofsky MJ, Hesse JE, Gellert M. Initiation of V(D)J recombination in a cell-free system. Cell. 1995;81:925-934[CrossRef][Medline] [Order article via Infotrieve]. 5. Sleckman BP, Gorman JR, Alt FW. Accessibility control of antigen-receptor variable-region gene assembly: role of cis-acting elements. Annu Rev Immunol. 1996;14:459-481[CrossRef][Medline] [Order article via Infotrieve]. 6. Szczepanski T, Beishuizen A, Pongers-Willemse MJ, et al. Cross-lineage T-cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B-acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease. Leukemia. 1999;13:196-205[CrossRef][Medline] [Order article via Infotrieve].
7.
Szczepanski T, Pongers-Willemse MJ, Langerak AW, et al.
Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage.
Blood.
1999;93:4079-4085 8. Yancopoulos GD, Alt FW. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell. 1985;40:271-281[CrossRef][Medline] [Order article via Infotrieve]. 9. Van Dongen JJM, Wolvers-Tettero ILM. Analysis of immunoglobulin and T-cell receptor genes, II: possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta. 1991;198:93-174[CrossRef][Medline] [Order article via Infotrieve]. 10. Ktorza S, Blanc C, Laurent C, et al. Complete TCR-delta rearrangements and partial (D-J) recombination of the TCR-beta locus in CD34+7+ precursors from human cord blood. J Immunol. 1996;156:4120-4127[Abstract].
11.
Blom B, Verschuren MCM, Heemskerk MHM, et al.
TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation.
Blood.
1999;93:3033-3043 12. Alt FW, Yancopoulos GD, Blackwell TK, et al. Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J. 1984;3:1209-1219[Medline] [Order article via Infotrieve].
13.
Strominger JL.
Developmental biology of T cell receptors.
Science.
1989;244:943-950 14. Raulet DH, Garman RD, Saito H, Tonegawa S. Developmental regulation of T-cell receptor gene expression. Nature. 1985;314:103-107[CrossRef][Medline] [Order article via Infotrieve].
15.
Bain G, Romanow WJ, Albers K, Havran WL, Murre C.
Positive and negative regulation of V(D)J recombination by the E2A proteins.
J Exp Med.
1999;189:289-300 16. Stanhope-Baker P, Hudson KM, Shaffer AL, Constantinescu A, Schlissel MS. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell. 1996;85:887-897[CrossRef][Medline] [Order article via Infotrieve]. 17. Murre C, McCaw PS, Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell. 1989;56:777-783[CrossRef][Medline] [Order article via Infotrieve].
18.
Bain G, Gruenwald S, Murre C.
E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins.
Mol Cell Biol.
1993;13:3522-3529 19. Shen CP, Kadesch T. B-cell-specific DNA binding by an E47 homodimer. Mol Cell Biol. 1995;15:4518-4524[Abstract]. 20. Bain G, Maandag EC, Izon DJ, et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements [comment appears in Cell. 1994;79:751-753]. Cell. 1994;79:885-892[CrossRef][Medline] [Order article via Infotrieve]. 21. Zhuang Y, Soriano P, Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell. 1994;79:875-884[CrossRef][Medline] [Order article via Infotrieve].
22.
Schlissel M, Voronova A, Baltimore D.
Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line.
Genes Dev.
1991;5:1367-1376 23. Romanow WJ, Langerak AW, Goebel P, et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell. 2000;5:343-353[CrossRef][Medline] [Order article via Infotrieve]. 24. Zhuang Y, Cheng P, Weintraub H. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol Cell Biol. 1996;16:2898-2905[Abstract]. 25. Rabbitts TH. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell. 1991;67:641-644[CrossRef][Medline] [Order article via Infotrieve]. 26. Schatz DG, Oettinger MA, Schlissel MS. V(D)J recombination: molecular biology and regulation. Annu Rev Immunol. 1992;10:359-383[Medline] [Order article via Infotrieve]. 27. Tycko B, Sklar J. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells. 1990;2:1-8[Medline] [Order article via Infotrieve]. 28. Hwang LY, Baer RJ. The role of chromosome translocations in T cell acute leukemia. Curr Opin Immunol. 1995;7:659-664[CrossRef][Medline] [Order article via Infotrieve].
29.
Pear WS, Nolan GP, Scott ML, Baltimore D.
Production of high-titer helper-free retroviruses by transient transfection.
Proc Natl Acad Sci U S A.
1993;90:8392-8396
30.
Kee BL, Murre C.
Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12.
J Exp Med.
1998;188:699-713
31.
Takebe Y, Seiki M, Fujisawa J, et al.
SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.
Mol Cell Biol.
1988;8:466-472
32.
Roman CA, Cherry SR, Baltimore D.
Complementation of V(D)J recombination deficiency in RAG-1( 33. Pongers-Willemse MJ, Seriu T, Stolz F, et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:110-118[CrossRef][Medline] [Order article via Infotrieve].
34.
Kneba M, Bolz I, Linke B, Hiddemann W.
Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis.
Blood.
1995;86:3930-3937 35. Breit TM, Verschuren MCM, Wolvers-Tettero ILM, Van Gastel-Mol EJ, Hählen K, van Dongen JJM. Human T cell leukemias with continuous V(D)J recombinase activity for TCR-delta gene deletion. J Immunol. 1997;159:4341-4349[Abstract]. 36. Langerak AW, Szczepanski T, van der Burg M, Wolvers-Tettero ILM, van Dongen JJM. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia. 1997;11:2192-2199[CrossRef][Medline] [Order article via Infotrieve]. 37. Pongers-Willemse MJ, Verhagen OJHM, Tibbe GJM, et al. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional regions specific TaqMan probes. Leukemia. 1998;12:2006-2014[CrossRef][Medline] [Order article via Infotrieve]. 38. Bruggemann M, Droese J, Bolz I, et al. Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR. Leukemia. 2000;14:1419-1425[CrossRef][Medline] [Order article via Infotrieve]. 39. Verhagen OJ, Willemse MJ, Breunis WB, et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia. 2000;14:1426-1435[CrossRef][Medline] [Order article via Infotrieve].
40.
Breit TM, Wolvers-Tettero ILM, Hählen K, van Wering ER, van Dongen JJM.
Extensive junctional diversity of
41.
Langerak AW, Wolvers-Tettero ILM, van den Beemd MWM, et al.
Immunophenotypic and immunogenotypic characteristics of TCR 42. Van den Beemd R, Boor PPC, van Lochem EG, et al. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry. 2000;40:336-345[CrossRef][Medline] [Order article via Infotrieve]. 43. Feddersen RM, Martin DJ, Van Ness BG. Novel recombinations of the IG kappa-locus that result in allelic exclusion. J Immunol. 1990;145:745-750[Abstract].
44.
Breit TM, Wolvers-Tettero ILM, Beishuizen A, Verhoeven M-AJ, van Wering ER, van Dongen JJM.
Southern blot patterns, frequencies and junctional diversity of T-cell receptor- 45. Langerak AW, Wolvers-Tettero ILM, van Dongen JJM. Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis. Leukemia. 1999;13:965-974[CrossRef][Medline] [Order article via Infotrieve]. 46. Moreau E, Langerak AW, van Gastel-Mol EJ, et al. Easy detection of all T cell receptor gamma (TCRG) gene rearrangements by Southern blot analysis: recommendations for optimal results. Leukemia. 1999;13:1620-1626[CrossRef][Medline] [Order article via Infotrieve]. 47. Szczepanski T, Langerak AW, Willemse MJ, Wolvers-Tettero ILM, van Wering ER, van Dongen JJM. T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia reflect "end-stage" recombinations: implications for minimal residual disease monitoring. Leukemia. 2000;14:1208-1214[CrossRef][Medline] [Order article via Infotrieve].
48.
Yokota S, Hansen-Hagge TE, Bartram CR.
T-cell receptor delta gene recombination in common acute lymphoblastic leukemia: preferential usage of V delta 2 and frequent involvement of the J alpha cluster.
Blood.
1991;77:141-148
49.
Krangel MS, Band H, Hata S, McLean J, Brenner MB.
Structurally divergent human T cell receptor 50. Massari ME, Grant PA, Pray-Grant MG, Berger SL, Workman JL, Murre C. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol Cell. 1999;4:63-73[CrossRef][Medline] [Order article via Infotrieve]. 51. Rabbitts TH, Lefranc MP, Stinson MA, et al. The chromosomal location of T-cell receptor genes and a T-cell rearranging gene: possible correlation with specific translocations in human T-cell leukemia. EMBO J. 1985;4:1461-1465[Medline] [Order article via Infotrieve].
52.
Breit TM, Mol EJ, Wolvers-Tettero IL, Ludwig WD, van Wering ER, van Dongen JJ.
Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
J Exp Med.
1993;177:965-977
© 2001 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
D. Wang, C. L. Claus, G. Vaccarelli, M. Braunstein, T. M. Schmitt, J. C. Zuniga-Pflucker, E. V. Rothenberg, and M. K. Anderson The Basic Helix-Loop-Helix Transcription Factor HEBAlt Is Expressed in Pro-T Cells and Enhances the Generation of T Cell Precursors J. Immunol., July 1, 2006; 177(1): 109 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Borghesi, J. Aites, S. Nelson, P. Lefterov, P. James, and R. Gerstein E47 is required for V(D)J recombinase activity in common lymphoid progenitors J. Exp. Med., December 19, 2005; 202(12): 1669 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Lin, T.-Y. Liu, S.-U. Chen, K.-T. Wang, L. J. Medeiros, and S.-M. Hsu CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features Blood, November 15, 2005; 106(10): 3567 - 3574. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fronkova, O. Krejci, T. Kalina, O. Horvath, J. Trka, and O. Hrusak Lymphoid Differentiation Pathways Can Be Traced by TCR {delta} Rearrangements J. Immunol., August 15, 2005; 175(4): 2495 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Dik, K. Pike-Overzet, F. Weerkamp, D. de Ridder, E. F.E. de Haas, M. R.M. Baert, P. van der Spek, E. E.L. Koster, M. J.T. Reinders, J. J.M. van Dongen, et al. New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling J. Exp. Med., June 6, 2005; 201(11): 1715 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Olaru, H. T. Petrie, and F. Livak Beyond the 12/23 Rule of VDJ Recombination Independent of the Rag Proteins J. Immunol., May 15, 2005; 174(10): 6220 - 6226. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Langerak, B. Nadel, A. de Torbal, I. L. M. Wolvers-Tettero, E. J. van Gastel-Mol, B. Verhaaf, U. Jager, and J. J. M. van Dongen Unraveling the Consecutive Recombination Events in the Human IGK Locus J. Immunol., September 15, 2004; 173(6): 3878 - 3888. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Szczepanski, V. H. J. van der Velden, P. G. Hoogeveen, M. de Bie, D. C. H. Jacobs, E. R. van Wering, and J. J. M. van Dongen V{delta}2-J{alpha} rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells Blood, May 15, 2004; 103(10): 3798 - 3804. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Krejci, Z. Prouzova, O. Horvath, J. Trka, and O. Hrusak Cutting Edge: TCR {delta} Gene Is Frequently Rearranged in Adult B Lymphocytes J. Immunol., July 15, 2003; 171(2): 524 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Asnafi, K. Beldjord, E. Boulanger, B. Comba, P. Le Tutour, M.-H. Estienne, F. Davi, J. Landman-Parker, P. Quartier, A. Buzyn, et al. Analysis of TCR, pTalpha , and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment Blood, April 1, 2003; 101(7): 2693 - 2703. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Roumier, V. Eclache, M. Imbert, F. Davi, E. MacIntyre, R. Garand, P. Talmant, P. Lepelley, J. L. Lai, O. Casasnovas, et al. M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Francais d'Hematologie Cellulaire (GFHC) and the Groupe Francais de Cytogenetique Hematologique (GFCH) Blood, February 15, 2003; 101(4): 1277 - 1283. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||